Freshfields Bruckhaus Deringer and Davis Polk & Wardwell are among the firms advising the underwriting syndicate for Swiss pharma Galderma Group’s IPO on the SIX Swiss Exchange. It is the latest IPO mandate for Freshfields which is helping CVC Capital Partners make its Amsterdam public debut.

The IPO values Galderma at around CHF15 billion ($17 billion), making it Switzerland’s largest IPO since 2017, according to the firms involved.